Exclusive interview with Paul Kasian, Chairman & CEO of Genetic Technologies (NASDAQ: GENE). GENE is a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms. GENE offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company lead products 'GeneType for Breast Cancer' and ‘GeneType for Colorectal Cancer’ are clinically validated risk assessment tests and are first in class. For more information, please visit genetechinfo.com.
The RedChip Money Report™ features interviews with public and private companies. The RedChip Money Report television show reaches more than 100 million homes on the Family Channel, American Business Television, The Action Channel, and Roku on Demand.
RedChip coordinates, writes and produces corporate videos with its in-house team of media experts, providing on-site production. In addition to IR-related videos, RedChip client companies use our expertise to develop and create videos for their products, services, and Press Releases.